Erythropoietin and Protection of Renal Function in Cardiac Surgery (the EPRICS Trial).

Alain Dardashti, Per Ederoth, Lars Algotsson, Björn Brondén, Edgars Grins, Mårten Larsson, Shahab Nozohoor, Galyna Zinko, Henrik Bjursten

Research output: Contribution to journalArticlepeer-review


To date, there are no known methods for preventing acute kidney injury after cardiac surgery. Increasing evidence suggests that erythropoietin has renal antiapoptotic and tissue protective effects. However, recent human studies have shown conflicting results. The authors aimed to study the effect of a single high-dose erythropoietin preoperatively on renal function after coronary artery bypass grafting in patients with preoperative impaired renal function.
Original languageEnglish
Pages (from-to)582-590
Issue number3
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Anesthesiology and Intensive Care


Dive into the research topics of 'Erythropoietin and Protection of Renal Function in Cardiac Surgery (the EPRICS Trial).'. Together they form a unique fingerprint.

Cite this